Budget Cuts Threaten Custom Rare Disease Treatments for Children: What’s Next for ARPA-H?
AI 요약 정보
- ARPA-H proposal falls nearly 28% to 107.367bn KRW
- HEART cuts could delay custom treatments for children aged 2-6
- HEART aims for 2027 trial approval and patient dosing in 2029